A number of other brokerages have also issued reports on LPNT. Mizuho reduced their price target on LifePoint Hospitals from $61.50 to $56.00 and set a neutral rating for the company in a research report on Monday, August 1st. Raymond James Financial Inc. dropped their price objective on LifePoint Hospitals from $75.00 to $65.00 and set an outperform rating on the stock in a research note on Tuesday, August 2nd. Royal Bank Of Canada dropped their price objective on LifePoint Hospitals from $84.00 to $77.00 and set an outperform rating on the stock in a research note on Monday, August 1st. Zacks Investment Research downgraded LifePoint Hospitals from a hold rating to a strong sell rating in a research note on Wednesday, September 28th. Finally, Wedbush reissued a neutral rating and issued a $66.00 price objective (down previously from $80.00) on shares of LifePoint Hospitals in a research note on Monday, August 1st. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eight have given a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of $72.06.
Shares of LifePoint Hospitals (NASDAQ:LPNT) opened at 59.43 on Friday. The firm has a 50-day moving average price of $57.52 and a 200-day moving average price of $64.07. LifePoint Hospitals has a 52 week low of $54.82 and a 52 week high of $76.39. The firm has a market capitalization of $2.54 billion, a price-to-earnings ratio of 19.79 and a beta of 0.89.
LifePoint Hospitals (NASDAQ:LPNT) last announced its quarterly earnings results on Friday, July 29th. The company reported $0.71 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by $0.19. LifePoint Hospitals had a return on equity of 7.14% and a net margin of 2.08%. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same quarter last year, the firm posted $1.00 EPS. The company’s revenue was up 25.3% compared to the same quarter last year. On average, equities analysts expect that LifePoint Hospitals will post $3.51 earnings per share for the current fiscal year.
Several large investors have recently made changes to their positions in LPNT. Riverhead Capital Management LLC raised its stake in shares of LifePoint Hospitals by 49.1% in the first quarter. Riverhead Capital Management LLC now owns 132,599 shares of the company’s stock worth $9,181,000 after buying an additional 43,687 shares during the period. State Street Corp raised its stake in shares of LifePoint Hospitals by 3.8% in the first quarter. State Street Corp now owns 1,245,127 shares of the company’s stock worth $86,231,000 after buying an additional 45,899 shares during the period. OMERS ADMINISTRATION Corp bought a new stake in shares of LifePoint Hospitals during the first quarter worth about $319,000. Acrospire Investment Management LLC acquired a new position in shares of LifePoint Hospitals during the first quarter worth $125,000. Finally, BlackRock Japan Co. Ltd increased its position in shares of LifePoint Hospitals by 223.5% in the first quarter. BlackRock Japan Co. Ltd now owns 15,337 shares of the company’s stock worth $1,062,000 after buying an additional 10,596 shares in the last quarter. 97.10% of the stock is currently owned by institutional investors.
LifePoint Hospitals Company Profile
LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.
Receive News & Ratings for LifePoint Hospitals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Hospitals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.